Inventor
Nicole Haubst
Inventor
Munich, DE
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
10,745,473Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules202010,080,800Antibodies for epidermal growth factor receptor 3 (HER3)201810,077,317Antibodies for epidermal growth factor receptor 3 (HER3)201810,000,561Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules20189,498,532'Antibody drug conjugates'20169,415,118'Antibody drug conjugates'20169,192,663'Antibodies for epidermal growth factor receptor 3 (HER3)'20158,735,551'Antibodies for epidermal growth factor receptor 3 (HER3)'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to NOVARTIS AG (8)· patent assignee history
2014–2016Patents assigned to ETTENBERG SETH ALEXANDER (2)· patent assignee history
2014–2016Patents assigned to HAUBST NICOLE (2)· patent assignee history
2014–2020Based in Munich, DE· patent location history
2016Patents assigned to BATT DAVID BRYANT (1)· patent assignee history
2016Patents assigned to BATT JULIE LYNN (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 8 | 2014–2020 |
| ETTENBERG SETH ALEXANDER | 2 | 2014–2016 |
| HAUBST NICOLEself | 2 | 2014–2016 |
| BATT DAVID BRYANT | 1 | 2016 |
| BATT JULIE LYNN | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Munich, DE | 8 | 2014–2020 |